Search
Sanofi: Beijing Insulin API Project Officially Launched with a Total Investment of Up to €1 Billion
2025-10-17 /
Read about 0 minute
Author：小编
Sanofi announced the official launch of its insulin active pharmaceutical ingredient (API) project in Yizhuang, Beijing. First unveiled in December 2024, this facility represents a total investment of €1 billion, marking it as the first insulin API production base established in China by a multinational pharmaceutical company. It is also the largest investment project in Beijing's pharmaceutical industry sector since the implementation of the 14th Five-Year Plan.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
